Ravikumar: GSK is paying Noetic $50 million for foundational model access
Vignesh Ravikumar · Why "SaaS Apocalypse" is the Best Filter for Top 1% of Founders | Vignesh Ravikumar, Sierra Ventures · Apr 30, 2026 · at 18:51
Sierra Ventures partner Vignesh Ravikumar discusses the rapid pace and massive check sizes of pharma adoption of healthcare AI models.
0:00 / 0:04exact quote · 4.1s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“GSK just said they were gonna pay him fifty million dollars for access to their model.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Vignesh Ravikumar
Ravikumar: Indian founders arriving in the US are more fully formed
“I think there's just something about founders when they're building in India today, they just have this, like, scrappiness, and by the time they come to the U.S., they feel a little bit more formed than a lot of the very raw companies you even see in the U.S.”
Ravikumar: Healthcare AI administrative and scribing markets are getting too crowded
“I think the admin side, your scribing tools, your RCM tools, the market is starting to get quite crowded. And well, I think there's some interesting companies that got an early advantage. I think if you're going to play in that space right now, it's just going…”
Ravikumar: Sierra Ventures stopped investing in traditional SaaS, focusing on AI-native
“And obviously as early stage investors, we're not investing in any SaaS companies anymore. Most of it is AI native building some sort of AI agents and stuff like that, but we don't see it as a, we don't see the SaaSpocalypse thing as a, as an inevitability.”
Ravikumar: Sierra Ventures' non-2012 funds generate 4x to 6x TVPI
“This would be 20... 12 and 20 12 vintage. And then the other funds are probably four to six X TVPI.”
Ravikumar: Sierra avoids early secondary sales to prevent negative signaling
“We've obviously, we'll consider secondaries, but I would say for the most part, one of the benefits of having Sierra on the cap table is the founders get a lot of reputational benefits as a result. So we try not to sell. We don't want to create any negative si…”